RecruitingNCT01019148
Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Sponsor
Stanford University
Enrollment
70 participants
Start Date
Nov 10, 2009
Study Type
OBSERVATIONAL
Conditions
Summary
Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by genetic mutations in the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening subjects with RDEB to evaluate characteristics of the subjects and their cells in order to develop new strategies of therapy and determine whether subjects could be candidates for treatment studies.
Eligibility
Inclusion Criteria2
- Clinical diagnosis of RDEB by local dermatologist
- years of age or older
Exclusion Criteria1
- Medical instability limiting ability to travel to Stanford University Medical Center
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01019148
Related Trials
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB)
NCT065634141 location
Study of the Blood and Skin Immunological Profile of Patients With Recessive Dystrophic Epidermolysis Bullosa: in Vivo Analysis and the Impact of Placental Stem Cells in Vitro
NCT061773532 locations